Fundraising Fox

Relievant Medsystems

Redwood City, US · Delaware corporation · 5 known investors

relievant.com ↗

Relievant offers the Intracept Procedure, a minimally invasive, FDA-cleared medical intervention designed to relieve chronic low back pain caused by vertebrogenic pain. The procedure targets patients with chronic low back pain seeking long-term pain relief and functional improvement.

Medical Devices

Founders & leadership

AD
Alex DiNelloExecutive

Board

RM
Richard MottBoard director
JKJustin Klein
Justin Kleinin𝕏Board directorCo-Founder and Managing Partner at Vensana Capital
BABrent Ahrens
Brent AhrensinBoard directorGeneral Partner at Canaan Partners
JL
Jason LettmanBoard director
JR
John RyanBoard director
AT
Art TaylorBoard director

Investors · 5

Canaan PartnersStamford · $500K – $20Mvia Brent Ahrens · board
Emergent Medical Partners, LLPSan Jose
Lightstone VenturesPortola Valley
New Enterprise Associates (NEA)Menlo Park · $200K – $40M
Vensana Capitalreported · 2 sourcesMinneapolisvia Justin Klein · board

Reported raises · per SEC filings

Form D private placements

$200.1M disclosed across 7 rounds · 2015–2023

▶$46MraisedMar 2023 · 12 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard MottDirector
  • Tyler BinneyDirector, Executive Officer
  • Ray Baker, MDExecutive Officer
  • Chris GeyenExecutive Officer
  • Cynthia LuccheseDirector
  • Brent AhrensDirector
  • Art TaylorDirector
  • Alexander SchmitzDirector
  • Ross JaffeDirector
  • David AmersonDirector
  • Justin KleinDirector
  • Jason LettmannDirector
Offering amount
$50M
Amount sold
$46M
First sale
Mar 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$69.7MraisedApr 2022 · 35 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Arthur TaylorDirector
  • Alexander SchmitzDirector
  • Justin KleinDirector
  • Chris GeyenExecutive Officer
  • Ross JaffeDirector
  • Tyler BinneyExecutive Officer, Director
  • Brent AhrensDirector
  • Ray BakerExecutive Officer
  • Jason LettmanDirector
  • David AmersonDirector
  • Richard MottDirector
Offering amount
$69.7M
Amount sold
$69.7M
First sale
Oct 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$57.7MraisedJul 2018 · 29 investors · Other Health Care
Rule 506(c)
Officers, directors & promoters on the filing
  • Jason LettmanDirector
  • Ray BakerExecutive Officer
  • Alexander SchmitzDirector
  • Richard MottDirector
  • Alex DiNelloExecutive Officer
  • Peter KleinDirector
  • Arthur TaylorDirector
  • Kevin HykesExecutive Officer, Director
  • Brent AhrensDirector
  • Chris GeyenExecutive Officer
Offering amount
$57.7M
Amount sold
$57.7M
Minimum investment
$1
First sale
Jun 2018
Incorporated
Corporation, Delaware
Federal exemptions
06c
Full filing on SEC EDGAR ↗
▶$22.2MraisedAug 2016 · 10 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Art TaylorDirector
  • Richard MottDirector
  • Brent AhrensDirector
  • Alex DiNelloExecutive Officer, Director
  • John RyanDirector
  • Justin KleinDirector
  • Jason LettmanDirector
Offering amount
$52.2M
Amount sold
$22.2M
First sale
Aug 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$49.2KraisedJan 2016 · 5 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Alex DiNelloExecutive Officer, Director
  • Richard MottDirector
  • Art TaylorDirector
  • Brent AhrensDirector
  • Justin KleinDirector
  • John RyanDirector
  • Jason LettmanDirector
Offering amount
$49.2K
Amount sold
$49.2K
First sale
Dec 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.5MraisedDec 2015 · 5 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard MottDirector
  • Justin KleinDirector
  • Brent AhrensDirector
  • Alex DiNelloExecutive Officer, Director
  • Art TaylorDirector
  • Jason LettmanDirector
  • John RyanDirector
Offering amount
$3M
Amount sold
$1.5M
First sale
Dec 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3MraisedFeb 2015 · 6 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Brent AhrensDirector
  • Richard MottDirector
  • Justin KleinDirector
  • Alex DiNelloExecutive Officer, Director
  • John RyanDirector
  • Art TaylorDirector
  • Jason LettmanDirector
Offering amount
$5M
Amount sold
$3M
First sale
Feb 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Relievant Medsystems do?
Relievant offers the Intracept Procedure, a minimally invasive, FDA-cleared medical intervention designed to relieve chronic low back pain caused by vertebrogenic pain. The procedure targets patients with chronic low back pain seeking long-term pain relief and functional improvement.
Who are Relievant Medsystems's investors?
Relievant Medsystems's investors include Canaan Partners, Emergent Medical Partners, LLP, Lightstone Ventures, New Enterprise Associates (NEA), Vensana Capital.
How much funding has Relievant Medsystems raised?
Relievant Medsystems has disclosed $200.1M raised across 7 rounds.
Where is Relievant Medsystems headquartered?
Relievant Medsystems is headquartered in Redwood City, US.